No takes yet. Share an insight, caveat, or question.
Review finds that Keap1-Nrf2 pathway activation improves neuronal health in neurodegenerative diseases, suggesting its potential as a therapeutic target.
Udi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: